A detailed history of Financial Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Financial Advisors, LLC holds 1,244 shares of AMGN stock, worth $397,557. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,244
Previous 1,244 -0.0%
Holding current value
$397,557
Previous $353,000 9.92%
% of portfolio
0.08%
Previous 0.07%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

BUY
$255.7 - $288.46 $255 - $288
1 Added 0.08%
1,244 $358,000
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $60,921 - $77,408
-266 Reduced 17.63%
1,243 $326,000
Q4 2021

Feb 11, 2022

SELL
$198.88 - $227.6 $46,736 - $53,486
-235 Reduced 13.47%
1,509 $339,000
Q1 2021

Apr 16, 2021

SELL
$221.91 - $258.6 $11,095 - $12,930
-50 Reduced 2.79%
1,744 $434,000
Q4 2019

Feb 13, 2020

BUY
$189.21 - $243.2 $3,973 - $5,107
21 Added 1.18%
1,794 $432,000
Q4 2018

Feb 14, 2019

BUY
$178.4 - $208.25 $316,303 - $369,227
1,773 New
1,773 $345,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Financial Advisors, LLC Portfolio

Follow Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial Advisors, LLC with notifications on news.